IIL produces first lot of Covaxin Drug Substance in record time

Hands over the first consignment of drug substance to Bharat Biotech

Dr K Anand Kumar, MD, Indian Immunologicals Ltd (IIL) handed over the first lot of Covaxin Drug Substance to Dr Krishna Ella, CMD, Bharat Biotech.


Speaking on this occasion, Dr Kumar said that “This could not have been possible without the coming together of several stakeholders to achieve a common goal. Our capable team worked tirelessly round the clock to ensure that the committed timelines and product quality are met. It is a proud moment for IIL to have played a vital role in supporting our Nation’s interest during this unprecedented time. This would have not been possible without the constant support provided by Niti-Aayog, BIRAC, DBT, Mission Covid Suraksha Team, Central and State drug control authorities.”

Speaking on this achievement, Dr Renu Swarup, Secretary, DBT and Chairperson, BIRAC said, ‘’The government has worked relentlessly to provide all possible support for ramping up Covaxin production in the country and speed up Covaxin inoculation drive. The loan license agreement by CDSCO for IIL to produce Covaxin Drug Substance is a major milestone, achieved in a very short period. The DBT-BIRAC support under Mission Covid Suraksha aims to meet the COVID-19 vaccine requirement of our country. I congratulate the team for the efforts put in for this achievement”.

“IIL is also working on another COVID -19 vaccine and the animal trials are underway currently and is expected to come out by next year for human vaccination,” added Dr Kumar.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.


Related Articles

Leave a Reply

Back to top button